AptarGroup Stock (NYSE:ATR)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$124.45

52W Range

$103.23 - $164.28

50D Avg

$119.45

200D Avg

$125.30

Market Cap

$8.01B

Avg Vol (3M)

$503.06K

Beta

0.39

Div Yield

$1.89 (1.51%)

ATR Company Profile


AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

13,000

IPO Date

Apr 23, 1993

Website

ATR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 22Dec 21
Beauty Segment$1.31B--
Pharma Segment$1.74B--
Beauty And Home-$1.46B$1.43B
Pharma-$1.37B$1.28B
Food + Beverage-$523.64M$508.57M

Fiscal year ends in Dec 25 | Currency in USD

ATR Financial Summary


Dec 25Dec 24Dec 23
Revenue$3.78B$3.58B$3.49B
Operating Income$510.88M$496.50M$404.02M
Net Income$392.79M$374.54M$284.49M
EBITDA$831.48M$777.45M$663.84M
Basic EPS$5.97$5.65$4.34
Diluted EPS$5.89$5.53$4.25

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 01, 26 | 12:00 AM
Q4 25Feb 06, 26 | 9:00 AM
Q3 25Oct 31, 25 | 9:00 AM

Peer Comparison


TickerCompany
RGENRepligen Corporation
MOHMolina Healthcare, Inc.
TFXTeleflex Incorporated
GRFSGrifols, S.A.
AVTRAvantor, Inc.
GMEDGlobus Medical, Inc.
HALOHalozyme Therapeutics, Inc.
STVNStevanato Group S.p.A.
HSICHenry Schein, Inc.